Circulating Tumor Cells Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024 Circulating tumor cells (CTCs) are cells which detach from its primary or secondary tumors, enters in to the bloodstream and travel to distant organs. This is the evolving field of medical science which are tremendously used in cases of cancer research. CTCs also helps to develope more effective cancer therapeutics and to understand the complex processes which leads to cancer metastasis. Apart from research applications, CTCs have enormous use in diagnosis and management of cancer. Browse
Complete
Report
@
https://www.variantmarketresearch.com/report-
categories/life-sciences/circulating-tumor-cells-market
CTC market is anticipated to witness huge growth in forecasted period due to increasing prevalence of cancer globally. Moreover, aging population, increasing awareness about lifestyle induced diseases such as diabetes and obesity; technological advancements are major factors which are contributing to the growth of this market. However, high cost of the CTCs diagnostics VARIANT MARKET RESEARCH
1
treatment, lack of awareness about advanced technologies, and unwillingness for the adoption of these technologies hampering the growth of this market. Furthermore, initiatives taken by the governments and increasing R&D cost has created numerous opportunities in the forecasted future. Get Sample Copy of This Report @ http://bit.ly/2qQ6kPz By technology, global market for CTCs is segmented into three major segments such as CTC Enrichment, CTC Detection and CTC Analysis. The CTC Enrichment segment is further subsegmented into in-vivo positive selection, ex-vivo positive selection, microchips, negative selection and single spiral micro channel. On the other hand, the CTC detection segment is divided into molecular (RNA) based technologies, immunocytochemical technologies, xenotransplantation models, EPISOT functional in-vitro cell culture and functional in-vitro cell invasion assay. On the basis of application, CTCs market is bifurcated into EMT biomarkers development, tumorigenesis research, cancer stem cell research and others. On the basis of geography, the global regenerative medicines market is segmented as North America (U.S., Mexico and Canada), Europe (U.K., Russia, Germany, Italy, France and others), Asia Pacific (China, India, Japan, South Korea, Taiwan and others) and rest of the world (RoW) (South America, Middle East and Africa). The key players of CTCs market are Clear Bridge Bio Medics, Janssen Diagnostics, LLC, Canopus Biosciences ltd, Apo cell, Advanced Cell Diagnostics, Miltenyi Biotech Cynvenio Biosystems, Vitatex Inc., Biocept Inc., Aviva Biosciences, Creative Microtech Inc. and Biocep Ltd. Scope of Circulating Tumor Cells Market Technology Segments •
•
CTC Enrichment o
In-vivo positive selection
o
Ex-vivo positive selection
o
Microchips
o
Negative selection
o
Single spiral micro channel
CTC Detection o
Molecular (RNA) based technologies
VARIANT MARKET RESEARCH
2
•
o
Immunocytochemical technologies
o
Xenotransplantation models
o
EPISOT functional in-vitro cell culture
o
Functional in-vitro cell invasion assay
CTC Analysis
Application Segments •
EMT biomarkers development
•
Tumorigenesis research
•
Cancer stem cell research
•
Others
Geographical Segments •
•
•
•
North America o
U.S.
o
Mexico
o
Canada
Europe o
U.K.
o
France
o
Russia
o
Germany
o
Italy
o
Others
Asia-Pacific o
China
o
India
o
Japan
o
South Korea
o
Taiwan
o
Others
RoW o
Latin America
o
Middle East
VARIANT MARKET RESEARCH
3
o
Africa
Contact Us: VARIANT MARKET RESEARCH LLP Web: https://www.variantmarketresearch.com/ USA Office: 649 Mission St., 5th Floor, San Francisco, CA 94105, United States. Tel: +1-415-680-2785 Fax: +1-415-680-2786 Email: help@variantmarketresearch.com India Office (Corporate Headquarter): Office No. FL No.7, Prakash Developers, Survey no 34/A5, Wadgaon Sheri, Nagar Road, Pune – 411014 Tel: +91 20 65337795
VARIANT MARKET RESEARCH
4